Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Safety and Pharmacokinetics of Oleander 4X in Healthy Volunteers
NCT04674709Phase 1Unknown
- Sponsor
- Avila Herbals
- Start
- Nov 2020
- Primary completion
- Jan 2021
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 1, randomised, double-blind trial of nerium oleander in influenza and influenza-like illness (ILI) (2 arms), sponsored by Avila Herbals. Primary endpoints: Number of participants with adverse events, serious event, and any related reactions and Proportion of subjects undergoing Dose Limiting Toxicity (DLT) events. Status: unknown.
02
Drugs
nerium oleander
03
Conditions
influenzainfluenza-like illness (ILI)
Beyond the preview
Go deeper on NCT04674709.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT04674709.